TherapeuticsMD (TXMD) Current Assets (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Current Assets came in at $15.3 million in Q1 2026, up 21.99% YoY from $12.5 million in Q1 2025, and up 5.66% on a QoQ basis from $14.4 million in Q4 2025.
TherapeuticsMD (TXMD) Current Assets (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Current Assets data on file, last reported at $15.3 million in Q1 2026.
- Quarterly Current Assets rose 21.99% year-over-year to $15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 21.99% YoY) and the FY2025 annual result came in at $14.4 million, up 17.83% from the prior year.
- Current Assets climbed to $15.3 million in Q1 2026, from $14.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $98.6 million in Q2 2022 to a low of $11.5 million in Q1 2024.
- A 5-year average of $30.4 million and a median of $14.5 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets slumped 80.11% — and 2026, when it advanced 21.99%.
- Tracing TXMD's Current Assets over 5 years: stood at $55.4 million in 2022, then plunged by 78.69% to $11.8 million in 2023, then gained by 3.93% to $12.3 million in 2024, then increased by 17.83% to $14.4 million in 2025, then grew by 5.66% to $15.3 million in 2026.
- The last three Current Assets figures came in at $15.3 million (Q1 2026), $14.4 million (Q4 2025), and $14.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 16.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.12 Mn |
| Mar 31, 2026 | 15.26 Mn |
| Dec 31, 2025 | 14.45 Mn |
| Sep 30, 2025 | 14.50 Mn |
| Jun 30, 2025 | 13.46 Mn |
| Mar 31, 2025 | 12.51 Mn |
| Dec 31, 2024 | 12.26 Mn |
| Sep 30, 2024 | 12.15 Mn |
| Jun 30, 2024 | 11.82 Mn |
| Mar 31, 2024 | 11.52 Mn |
| Dec 31, 2023 | 11.80 Mn |
| Sep 30, 2023 | 17.44 Mn |
| Jun 30, 2023 | 19.61 Mn |
| Mar 31, 2023 | 24.74 Mn |
| Dec 31, 2022 | 55.35 Mn |
| Sep 30, 2022 | 87.48 Mn |
| Jun 30, 2022 | 98.60 Mn |
| Mar 31, 2022 | 84.42 Mn |
| Dec 31, 2021 | 119.47 Mn |
| Sep 30, 2021 | 159.98 Mn |